North America Point of Care Testing Market By Product Type (Infectious Diseases Testing, Blood Glucose Monitoring, Cardiac Testing, Coagulation Testing, Fertility Testing, Drug Abuse Testing, Respiratory Testing, Others), By Sample Type (Blood Samples, Respiratory Samples, Urine Samples, Saliva Samples, Fecal Samples, Tissue Samples, Other), By Technology (Immunoassays, Molecular Diagnostics, Electrochemical Detection, Optical Detection, Bio Sensors, Microfluidics, Imaging Technology, Wearable Technology, Others), Market Size, Segmental analysis, Country Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Published Date: Oct 2024 | Report ID: MI1172 | 220 Pages

Table of Contents

1. Methodology & Report Coverage

1.1. Definition & Objective

1.2. Market Evaluation & forecast parameter

1.3. Research Methodology

1.4. Data Validation Sources

1.4.1. Secondary Research

1.4.2. Primary Research

2. Market Overview

3. North America Point of Care Testing Market: Market Dynamics

3.1. Executive Summary

3.2. Market Driving Factors

3.2.1. The Importance of Point of Care Testing in Emergency and Acute Care Settings

3.2.2. Innovations Enhancing Usability and Reliability in Point of Care Testing Devices

3.2.3. Enhancing Chronic Disease Management with Point of Care Testing Solutions

3.3. Key industry pitfalls & challenges

3.3.1. Financial Barriers to Adopting Advanced Point of Care Testing in Smaller Clinics

3.3.2. Impact of Regulatory Requirements on the Approval Process for New Point of Care Testing Devices

3.3.3. The Impact of Awareness on Market Growth for Point of Care Testing Solutions

3.4. Market Opportunities

3.4.1. Unlocking Market Potential with Opportunities in Specialized Point of Care Testing for Targeted Health Conditions

3.4.2. Investing in R&D for Advanced Point of Care Testing Technologies

3.4.3. The Vital Role of Point of Care Testing in Early Disease Detection and Preventive Healthcare

3.5. Porter’s Five Forces Analysis

3.6. PESTLE Analysis

3.7. Regulatory landscape

3.8. Investment landscape

3.9. ESG Scenario

3.10. Competitive landscape

3.10.1. Company Market Share

3.10.2. Market Positioning

3.10.3. Strategy framework

3.10.4. Recent Acquisitions & Mergers

4. North America Point of Care Testing Market, Product Type Segment Analysis

4.1. Overview Dynamics

4.1.1. Market Revenue Share, By Product Type, 2025 & 2035

4.1.2. Key Market Trends, Growth Factors, & Opportunities

4.2. Infectious Diseases Testing

4.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3. Blood Glucose Monitoring

4.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.4. Cardiac Testing, Coagulation Testing

4.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.5. Fertility Testing

4.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.6. Drug Abuse Testing

4.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.7. Respiratory Testing

4.7.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.8. Others

4.8.1. Market Size and Forecast, 2025-2035 (USD Billion)

5. North America Point of Care Testing Market, Sample Segment Analysis

5.1. Overview

5.1.1. Market Revenue Share, By Sample, 2025 & 2035

5.1.2. Key Market Trends, Growth Factors, & Opportunities

5.2. Blood Samples

5.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.3. Respiratory Samples

5.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.4. Urine Samples

5.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.5. Saliva Samples

5.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.6. Fecal Samples

5.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.7. Tissue Samples

5.7.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.8. Other

5.8.1. Market Size and Forecast, 2025-2035 (USD Billion)

6. North America Point of Care Testing Market, Technology Segment Analysis

6.1. Overview

6.1.1. Market Revenue Share, By Technology, 2025 & 2035

6.1.2. Key Market Trends, Growth Factors, & Opportunities

6.2. Immunoassays

6.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.3. Molecular Diagnostics

6.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.4. Electrochemical Detection

6.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.5. Optical Detection

6.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.6. Bio Sensors

6.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.7. Microfluidics

6.7.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.8. Imaging Technology

6.8.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.9. Wearable Technology

6.9.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.10. Others

6.10.1. Market Size and Forecast, 2025-2035 (USD Billion)

7. North America Point of Care Testing Market, Region Segment Analysis

7.1. Overview

7.1.1. Global Market Revenue Share, By Region, 2025 & 2035

7.1.2. Global Market Revenue, By Region, 2025-2035 (USD Billion)

7.2. North America

7.2.1. North America Market Revenue, By Country, 2025-2035 (USD Billion)

7.2.2. North America Market Revenue, By Product Type, 2025-2035

7.2.3. North America Market Revenue, By Sample, 2025-2035

7.2.4. North America Market Revenue, By Technology, 2025-2035

7.2.5. The U.S.

7.2.5.1. U.S. Market Revenue, By Product Type, 2025-2035

7.2.5.2. U.S. Market Revenue, By Sample, 2025-2035

7.2.5.3. U.S. Market Revenue, By Technology, 2025-2035

7.2.6. Canada

7.2.6.1. Canada Market Revenue, By Product Type, 2025-2035

7.2.6.2. Canada Market Revenue, By Sample, 2025-2035

7.2.6.3. Canada Market Revenue, By Technology, 2025-2035

8. Company Profile

8.1. Abbott Laboratories

8.1.1. Business Overview

8.1.2. Financial Performance

8.1.3. Product/Service Offerings

8.1.4. Strategies & recent developments

8.1.5. SWOT Analysis

8.2. BD (Becton, Dickinson and Company)

8.2.1. Business Overview

8.2.2. Financial Performance

8.2.3. Product/Service Offerings

8.2.4. Strategies & recent developments

8.2.5. SWOT Analysis

8.3. Thermo Fisher Scientific

8.3.1. Business Overview

8.3.2. Financial Performance

8.3.3. Product/Service Offerings

8.3.4. Strategies & recent developments

8.3.5. SWOT Analysis

8.4. Roche Diagnostics

8.4.1. Business Overview

8.4.2. Financial Performance

8.4.3. Product/Service Offerings

8.4.4. Strategies & recent developments

8.4.5. SWOT Analysis

8.5. Quidel Corporation

8.5.1. Business Overview

8.5.2. Financial Performance

8.5.3. Product/Service Offerings

8.5.4. Strategies & recent developments

8.5.5. SWOT Analysis

8.6. Cepheid

8.6.1. Business Overview

8.6.2. Financial Performance

8.6.3. Product/Service Offerings

8.6.4. Strategies & recent developments

8.6.5. SWOT Analysis

8.7. PerkinElmer

8.7.1. Business Overview

8.7.2. Financial Performance

8.7.3. Product/Service Offerings

8.7.4. Strategies & recent developments

8.7.5. SWOT Analysis

8.8. Hologic

8.8.1. Business Overview

8.8.2. Financial Performance

8.8.3. Product/Service Offerings

8.8.4. Strategies & recent developments

8.8.5. SWOT Analysis

8.9. Bio Rad Laboratories

8.9.1. Business Overview

8.9.2. Financial Performance

8.9.3. Product/Service Offerings

8.9.4. Strategies & recent developments

8.9.5. SWOT Analysis

8.10. Luminex Corporation

8.10.1. Business Overview

8.10.2. Financial Performance

8.10.3. Product/Service Offerings

8.10.4. Strategies & recent developments

8.10.5. SWOT Analysis

8.11. OraSure Technologies

8.11.1. Business Overview

8.11.2. Financial Performance

8.11.3. Product/Service Offerings

8.11.4. Strategies & recent developments

8.11.5. SWOT Analysis

8.12. Acon Laboratories

8.12.1. Business Overview

8.12.2. Financial Performance

8.12.3. Product/Service Offerings

8.12.4. Strategies & recent developments

8.12.5. SWOT Analysis

8.13. AccuMedical

8.13.1. Business Overview

8.13.2. Financial Performance

8.13.3. Product/Service Offerings

8.13.4. Strategies & recent developments

8.13.5. SWOT Analysis

8.14. MedMira

8.14.1. Business Overview

8.14.2. Financial Performance

8.14.3. Product/Service Offerings

8.14.4. Strategies & recent developments

8.14.5. SWOT Analysis

8.15. HCA Healthcare

8.15.1. Business Overview

8.15.2. Financial Performance

8.15.3. Product/Service Offerings

8.15.4. Strategies & recent developments

8.15.5. SWOT Analysis

 

Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!

Our analysts are ready to help you immediately.